Literature DB >> 19593228

Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis.

Miguel A Gonzalez-Gay1, Tomas R Vazquez-Rodriguez, Ines Gomez-Acebo, Robustiano Pego-Reigosa, Maria J Lopez-Diaz, Matilde C Vazquez-Triñanes, Jose A Miranda-Filloy, Ricardo Blanco, Trinidad Dierssen, Carlos Gonzalez-Juanatey, Javier Llorca.   

Abstract

Patients with giant cell arteritis (GCA) generally present with cranial ischemic manifestations that are directly related to vascular involvement. They may also experience strokes in the territory of the carotid or the vertebrobasilar artery. We conducted the current study to assess the frequency and predictors of strokes in general, and of vertebrobasilar stroke in particular, at the time of diagnosis in a series of 287 consecutive patients with biopsy-proven GCA diagnosed over a 27-year period at the single hospital for a well-defined population of northwestern Spain.During the study period, 8 (2.8%) patients had strokes (1 in the carotid and 7 in the vertebrobasilar territory) between the onset of symptoms of the disease and 4 weeks after the onset of corticosteroid therapy. Six of the 7 patients with vertebrobasilar stroke were men. In most cases the vertebrobasilar stroke occurred after the onset of corticosteroid therapy. Smoking history was more common among patients with vertebrobasilar stroke (p = 0.01). Patients with vertebrobasilar stroke more commonly had permanent visual loss due to arteritic involvement of ophthalmic branches derived from the internal carotid (3/7; 42.9%) than the rest of GCA patients (33/280; 11.8%) (p = 0.05). Patients with strokes had higher hemoglobin values (13.2 +/- 1.5 g/dL) than patients without (11.7 +/- 1.6 g/dL) (p = 0.009). Moreover, only 1 (14.3%) of the 7 patients with vertebrobasilar stroke had anemia compared to 157 (56.1%) of the remaining 280 patients (p = 0.05). The best predictors of stroke were permanent visual loss (odds ratio [OR], 5.42) and arterial hypertension (OR, 5.06). In contrast, women (OR, 0.10) and patients with anemia at the time of disease diagnosis (OR, 0.11) had a significantly reduced risk of suffering strokes. Smoking history was the best positive predictor of vertebrobasilar stroke (OR, 5.22). In contrast, a reduced risk of suffering vertebrobasilar strokes was found in individuals who had anemia at the time of GCA diagnosis (OR, 0.13).Results of the current study show an increased risk of strokes, in the vertebrobasilar territory in particular, at the time of GCA diagnosis. Patients with biopsy-proven GCA and traditional cardiovascular risk factors or permanent visual loss have an increased risk of suffering strokes. Results also suggest a potential protective role of anemia against the development of these cerebrovascular complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593228     DOI: 10.1097/MD.0b013e3181af4518

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  46 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

3.  [Neurological manifestations of vasculitis and primary central nervous system vasculitis].

Authors:  T Magnus; A Melms; I Kötter; J U Holle
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

Review 4.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

Review 5.  Giant Cell Arteritis: Practical Pearls and Updates.

Authors:  Swati Pradeep; Jonathan H Smith
Journal:  Curr Pain Headache Rep       Date:  2018-01-17

6.  Clinical Reasoning: A 77-year-old man presenting with episodic expressive aphasia.

Authors:  Alice Shanklin; Andrew Cox; Hamdy M A Ahmed; Alicia Lieberman; Ania Busza
Journal:  Neurology       Date:  2018-05-15       Impact factor: 9.910

7.  Morphological features of temporal arteritis.

Authors:  William C Roberts; Saleha Zafar; Jo Mi Ko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

8.  A hidden giant: Wallenberg syndrome and aortal wall thickening as an atypical presentation of a giant cell arteritis.

Authors:  Katharina Luisa Stengl; Ralph Buchert; Hans Bauknecht; Jan Sobesky
Journal:  BMJ Case Rep       Date:  2013-03-01

9.  Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis.

Authors:  Thierry Zenone; Marie Puget
Journal:  Rheumatol Int       Date:  2013-07-20       Impact factor: 2.631

10.  Acute Lateral Medullary Infarct due to Giant Cell Arteritis: A Case Study.

Authors:  Joseph M Dardick; Charles C Esenwa; Richard L Zampolin; Berrin Ustun; Bibi Ayesha; Kathryn F Kirchoff-Torres; Ava L Liberman
Journal:  Stroke       Date:  2019-09-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.